SRF Share Price: Sharekhan maintains Buy rating with Price target of Rs 8100
SRF Share price: Sharekhan says that SRF Q4FY2021 results were significantly ahead of estimates with a big beat of 17% in revenues at Rs. 2,608 crore (up 40.4% yoy; up 21.5% qoq). Robust revenue growth reflects strong demand traction across businesses and the same is clearly visible in the 31%/63%/26% y-o-y rise in revenues of chemical/ packaging/technical textiles segments to Rs. 1,153 crore/Rs. 980 crore/Rs. 401 crore
SRF Share price: Sharekhan says that SRF Q4FY2021 results were significantly ahead of estimates with a big beat of 17% in revenues at Rs. 2,608 crore (up 40.4% yoy; up 21.5% qoq). Robust revenue growth reflects strong demand traction across businesses and the same is clearly visible in the 31%/63%/26% y-o-y rise in revenues of chemical/ packaging/technical textiles segments to Rs. 1,153 crore/Rs. 980 crore/Rs. 401 crore. Growth in the chemicals segment was driven by strong demand for specialty chemicals in the export market (especially Europe), higher volume for refrigerants in the fluorochemicals and healthy contribution from the chloromethane segment. Packaging segment benefited from higher volume and ramp-up of new capacities in Thailand and Hungary. A recovery in the tyre industry led to strong revival and growth in the technical textiles segment.
However, adjusted OPM (adjusted for a forex gain of Rs. 9 crore) at 24% (up 161 bps yoy) marginally missed our estimate by 87 bps on account of a 61 bps yoy contraction in gross margins to 50%, given the sharp jump in the input costs. Consequently, adjusted operating profit grew sharply by 50.5% yoy (up 19.5% qoq) to Rs. 625 crore, 13%/9% above our and consensus estimate. The EBIT margin from chemical and technical textiles increased by 586/642 bps yoy to 23.9%/18.2%. However, EBIT margin of the packaging segment declined by 417 bps qoq (up only 58 bps yoy) to 22.3%, says Sharekhan.
See Zee Business Live TV Streaming Below:
Sharekhan added that Adjusted PAT at Rs. 372 crore (up 68.3% yoy; up 23% qoq) was 21%/15% above our and consensus estimate led by strong performance from the chemical and technical textiles segments. In terms of outlook, management has guided for 10-15% y-o-y revenue growth for the specialty chemical business on a high base of FY2021 (revenue increased by ~45% y-o-y) and expects that near-term margin in the packaging films business could remain good as there has been delay in commissioning to new capacities. SRF’s high capex intensity towards the chemical business (60-70% of the planned capex of Rs. 1,600-1,900 crore for FY2022) would drive sustained high earnings growth in FY2023 and beyond.
The potential increase in the share of high-growth specialty chemicals businesses in overall business mix over next few years would act as a key rating catalyst for SRF. In addition, Sharekhan believes that structural high growth cycle for Indian specialty chemicals sector (expected to grow at a 9% CAGR over 2019-2025) given favourable dynamics (China Plus One strategy by global companies) to support premium valuation for quality players like SRF. Hence, Sharekhan maintains a Buy on SRF with a revised Price target of Rs 8100.
SRF Key positives:
Strong revenue growth of 31%/63%/26% y-o-y for chemicals/packaging film/technical textiles segments
EBIT margin from chemical/technical textiles expanded by 586/624 bps y-o-y to 23.9%/18.2%
|SRF Key negatives:
EBIT margin in packaging segment declined by 417 bps q-o-q to 22.3%
SRF Key Risks:
Slower offtake from user industries and concerns on a correction in product prices can impact revenue growth
Input cost price volatility might impact margins.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
10:10 AM IST